Literature DB >> 6377994

A controlled trial of intermittent positive pressure breathing, incentive spirometry, and deep breathing exercises in preventing pulmonary complications after abdominal surgery.

B R Celli, K S Rodriguez, G L Snider.   

Abstract

Controversy exists regarding the routine use of aids to lung expansion in the prevention of pulmonary complications after abdominal surgery. We prospectively randomized 172 patients into 1 of 4 groups: the control group (44 patients) received no respiratory treatment, the IPPB group (45 patients) received intermittent positive pressure breathing therapy for 15 min 4 times daily, the IS group (42 patients) was treated with incentive spirometry 4 times daily, and the DBE group (41 patients) carried out deep breathing exercises under supervision for 15 min 4 times daily. Roentgenographic changes, observed 24 h after surgery, were comparable in the 4 groups (20.5 to 36.6%). Pulmonary complications were defined as the development of 3 or more of 6 new findings: cough, phlegm, dyspnea, chest pain, temperature greater than 38 degrees C, pulse rate more than 100 beats/min. The frequency of development of pulmonary complications was 48% in the control group, 22% in the IPPB group (p less than 0.05), 21% in the IS group (p less than 0.05), and 22% in the DBE group (p less than 0.05). Side effects of respiratory treatment were observed only in the IPPB group (18%; p less than 0.05). Hospital stay in patients undergoing upper abdominal surgery was significantly shorter in the IS group (mean +/- SD, 8.6 +/- 3 days) than in the control group (13 +/- 5 days). This difference was not observed for the other 2 treatment groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6377994     DOI: 10.1164/arrd.1984.130.1.12

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  33 in total

Review 1.  Surgery and the respiratory muscles.

Authors:  N M Siafakas; I Mitrouska; D Bouros; D Georgopoulos
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

Review 2.  Perioperative functional residual capacity.

Authors:  R W Wahba
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 3.  [Postoperative pulmonary complications: prophylaxis after noncardiac surgery].

Authors:  S Hofer; J Plachky; R Fantl; J Schmidt; H J Bardenheuer; M A Weigand
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

Review 4.  Overview of the perioperative management of lung volume reduction surgery patients.

Authors:  Amir Sharafkhaneh; Jeremy A Falk; Omar A Minai; David A Lipson
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 5.  Effects of laparoscopic cholecystectomy on lung function: a systematic review.

Authors:  George D Bablekos; Stylianos A Michaelides; Antonis Analitis; Konstantinos A Charalabopoulos
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 6.  Cost-effective use of the surgical intensive care unit.

Authors:  S D Eyer; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

7.  Effect of Incentive Spirometry on Postoperative Hypoxemia and Pulmonary Complications After Bariatric Surgery: A Randomized Clinical Trial.

Authors:  Haddon Pantel; John Hwang; David Brams; Thomas Schnelldorfer; Dmitry Nepomnayshy
Journal:  JAMA Surg       Date:  2017-05-01       Impact factor: 14.766

Review 8.  Postoperative pulmonary infections.

Authors:  Michelle Conde; Valerie Lawrence
Journal:  BMJ Clin Evid       Date:  2008-09-29

9.  Short-term respiratory physical therapy treatment in the PACU and influence on postoperative lung function in obese adults.

Authors:  Martin Zoremba; Frank Dette; Laura Gerlach; Udo Wolf; Hinnerk Wulf
Journal:  Obes Surg       Date:  2009-07-21       Impact factor: 4.129

10.  Effects of chest physiotherapy on the respiratory function of postoperative gastroplasty patients.

Authors:  Eli Forti; Daniela Ike; Marcela Barbalho-Moulim; Irineu Rasera; Dirceu Costa
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.